This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
NanoViricides receives regulatory approval in the DRC to begin a Phase II trial of NV-387 Oral Gummies for Ebola, amid an outbreak with over 4,100 confirmed cases and 1,889 deaths as of Aug. 6, 2026. #Ebola #Biotech
2026-08-10T17:01:12.772Z